跳至主要内容
临床试验/NL-OMON38446
NL-OMON38446已完成2 期

Safety and Performance of a Bioabsorbable Fluticasone Propionate-eluting sinus dressing (SinuBand) in the Postoperative management of Functional Endoscopic Sinus Surgery in patients with Chronic Rhinosinusitis - Sinuband in CRS

BioInspire Technologies0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients aged >18 years, with chronic rhinosinusitis (with nasal polyps), in whom bilateral endoscopic endonasal anterior and posterior ethmoidectomy is indicated due to failure of medical treatment, whether as first surgical approach or as revision surgery.

排除标准

  • Patients with a known history of corticosteroid (CS) intolerance will be excluded from the study, as well as those dependent on oral CS or with a history of immunodeficiency, fungal rhinosinusitis, previous nasal polyp surgery in which the middle turbinates have been removed on one or both sides, severe asthma, glaucoma, cataract, or insulin-dependent diabetes mellitus. Patients with known hypersensitivity to any component of SinuBand will be excluded from the study

研究者

发起方
BioInspire Technologies

相似试验